Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Effexor Birth Defects

Subscribe to Effexor Birth Defects RSS Feed

Prozac, Pazil, Zoloft, Celexa linked to Persistent Pulmonary Hypertension of the Newborn (PPHN)

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Titled “Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.”, this article appearing in the October, 2012 edition of CNS Drugs by M. Galbally et al., identifies persistent pulmonary hypertension of the newborn (PPHN) as a potential consequence of SSRI exposure before birth. Galbally et al. (2012) writes “Persistent… Continue Reading

2009 – More research links SSRIs with birth defects: heart defects, adverse birth outcomes

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

In 2009, S. Alwan and J.M. Friedman, a research duo from the University of British Columbia in Vancouver, published a study titled “Safety of selective serotonin reuptake inhibitors in pregnancy.” in CNS Drugs that provided important insight into the link between gestational exposure to selective serotonin reuptake inhibitor drugs (such as Prozac, Paxil, and Zoloft)… Continue Reading

Neonatal seizures from Effexor exposure; Effexor, SSRIs present in amniotic fluid

Posted in Effexor Birth Defects, SSRI Birth Defects

Here, I present two studies I read this morning concerning the connection between prenatal SSRI exposure and adverse perinatal outcomes.  selective serotonin reuptake inhibitor drugs (SSRIs) are widely used for a range of psychiatric ailments from depression to anxiety and work by regulating the concentration of serotonin molecules in the synapses between neurons.  Serotonin is… Continue Reading

European researchers find Effexor neonatal withdrawal and newborn intestinal tissue death from exposure

Posted in Effexor Birth Defects, SSRI Birth Defects

Over the past two decades, a number of scientific studies have demonstrated that exposure to selective serotonin reuptake inhibitor drugs (SSRIs) can have adverse effects on a developing fetus.  Here, I’ll reference a pair of European studies that cite these adverse effects. First, an article titled “[Withdrawal symptoms in a neonate following exposure to venlafaxine… Continue Reading

2007 – Adverse birth outcomes for babies exposed to Effexor, SSRIs during pregnancy

Posted in Effexor Birth Defects, SSRI Birth Defects

A study titled “Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.” published in the January, 2007 edition of Pediatrics by E. Ferreira et al. made great strides in elucidating the connection between preterm birth and gestational exposure to selective serotonin reuptake inhibitors or Effexor (venlafaxine). The team states,… Continue Reading

2010 – Scientists find link between low birth weight and SSRI exposure

Posted in Effexor Birth Defects, SSRI Birth Defects

An article published in the October, 2010 edition of Canadian Journal of Psychiatry by a team of researchers from Pfizer (Canada), led by É. Ramos, titled “Association between antidepressant use during pregnancy and infants born small for gestational age.” that sheds light on the connection between gestational exposure to SSRI drugs and low birth weight…. Continue Reading

2009 – Research shows SSRIs cross placenta

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Published in May, 2009 in Pharmacopsychiatry by a team of Australian researchers led by J. Rampono, an article titled “Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.” provides further evidence that drugs such as Celexa, Lexapro, Prozac, Paxil, Zoloft, Effexor and others may cross the placenta and affect a developing fetus…. Continue Reading

2013 – Hypospadias linked to Effexor in pregnancy

Posted in Effexor Birth Defects, SSRI Birth Defects

A 2013 article by J.N. Lind et al. published in Pharmacoepidemiology and Drug Safety titled “Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.” made links between Effexor and birth defects, and between Clomid and birth defects. Using “data from the National Birth Defects Prevention Study,… Continue Reading

2010 – Canadian study shows Paxil, Effexor raise risk for spontaneous abortion

Posted in Effexor Birth Defects, Paxil Birth Defects, SSRI Birth Defects

In 2010, an article published in Canadian Medical Association Journal titled “Use of antidepressants during pregnancy and the risk of spontaneous abortion.” illustrated the link between SSRI use during pregnancy and increased risk for spontaneous abortion. This study, led by H.R. Nakhai-Pour of The University of Montreal, “obtained data from the Quebec Pregnancy Registry for… Continue Reading

2010 – Paxil, Effexor dramatically raise risk for spontaneous abortion

Posted in Effexor Birth Defects, Paxil Birth Defects, SSRI Birth Defects

A recent article by P. Broy et al. published in Current Drug Delivery titled “Gestational exposure to antidepressants and the risk of spontaneous abortion: a review.” provides important insight into the connection between in vitro exposure to SSRI drugs and spontaneous abortion.  SSRI drugs are a relatively new class of antidepressant medications, which aim to… Continue Reading

2012 – SSRIs associated with spontaneous abortion

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Studies have shown that women suffering from depression during pregnancy can put the child at risk of developing malformations.  As such, selective serotonin reuptake inhibitors (SSRIs) are most commonly prescribed to the mother to avoid such complications.  Unfortunately, using these drugs during pregnancy may also put the child at risk of malformations.  To date, the… Continue Reading

2006 – Neonatal Abstinence Syndrome Seen in Children Exposed to SSRIs in Pregnancy

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

The objective of a study titled “Neonatal Abstinence Syndrome After in Utero Exposure to Selective Serotonin Reuptake inhibitors in Term Infants”, written by researchers from the Neonatal Intensive Care Unit at Schneider Children’s Medical Center of Israel, led by R. Levinson-Castiel was to determine the prevalence and clinical characteristics of neonatal abstinence syndrome in neonates… Continue Reading

Maternal use of Effexor, other SSRIs may result in neonatal abstinence syndrome

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

A study conducted by the Department of Psychological Medicine, King Edward Memorial Hospital for Women, Subiaco, Australia, titled “Placental Transfer of SSRI and SNRI Antidepressants and Effects On The Neonate”, investigated placental transfer and neurobehavioural effects in neonates exposed to venlafaxine (Effexor), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine, fluoxetine (Prozac), escitalopram, and citalopram (Celexa).  The neonates… Continue Reading

2004 – Doctors Avoid SSRIs in Pregnant Women

Posted in Celexa Birth Defects, Effexor Birth Defects, Paxil Birth Defects, Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

The objective of a study published by researchers from the OMNI Research Group within the Department of Obstetrics and Gynaecology at The University of Ottawa, in Ottawa ON, titled “The Use of Selective Serotonin Reuptake Inhibitors in Pregnancy”, was to update literature on the safety of using selective serotonin reuptake inhibitors during pregnancy. For this… Continue Reading

2012 – Study shows Effexor linked to birth defects

Posted in Effexor Birth Defects, SSRI Birth Defects

Studies have shown that 3 percent of pregnant women are treated with antidepressants during gestation.  This percentage is found to slightly increase after delivery of the baby, from 5-7 percent.  Fluoxetine, paroxetine, sertraline, citalopram, and venlafaxine (VENF) are all serotonin reuptake inhibitors or serotonin and noradrenaline reuptake inhibitors that are most commonly prescribed during pregnancy…. Continue Reading

Effexor, other SSRIs associated with serious congenital malformations

Posted in Effexor Birth Defects, SSRI Birth Defects

In 2004, research by F. Yaris et al. published in Reproductive Toxicology evaluated the safety of newer antidepressants in pregnancy. To-date, a number of antidepressant drugs, especially SSRIs (Paxil, Prozac, Celexa, Effexor, others) have been associated with a range of life-threatening birth defects. More information on SSRI and birth defects. This Yaris et al. (2004)… Continue Reading

Effexor, Paxil Associated with Fetal Heart Malformation

Posted in Effexor Birth Defects, Paxil Birth Defects, SSRI Birth Defects

A 2007 review published in Pharmacotherapy analyzed the effects of several common antidepressant medications during pregnancy and concluded that “Third-trimester exposure to newer antidepressants, including SSRIs and serotonin-norepinephrine reuptake inhibitors (e.g., venlafaxine), has been associated with a poor neonatal adaptation syndrome. In addition, SSRI use may be associated with an increased risk of persistent pulmonary… Continue Reading

Study Shows: Effexor Use in Pregnancy May Cause Birth Defects

Posted in Effexor Birth Defects, SSRI Birth Defects

Venlafaxine (Effexor) has become a popular antidepressant medication, used to treat major depression and anxiety disorders in adults.  The antidepressant has been widely used, seen as a highly effective medication for patients across a broad demographic.  A current study conducted by Kara Polen, et. al. concerned itself with the lack of research done on Venlafaxine’s… Continue Reading